Rebecca Bandea
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rebecca Bandea has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Januário Da Silva
Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Public Health Service, U.S. Department of Health and Human Services, Atlanta, Georgia
1 shared publication - Helena Lúcia Carneiro Santos
Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Doenças Parasitárias, Rio de Janeiro 21040-360, Brazil
1 shared publication - José Mauro Peralta
Universidade Federal do Rio de Janeiro, Brasil
1 shared publication - Kakali Bandyopadhyay
Center for Global Health, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA
1 shared publication - Regina Helena Saramago Peralta
Departamento de Patologia, Universidade Federal Fluminense, Niterói, RJ, Brazil
1 shared publication
Latest Publications
- Open Access
- 15 March 2013
- Published by Springer Nature in Parasites & Vectors
- Vol. 6 (1) , 69
LUMINEX®: a new technology for the simultaneous identification of five Entamoeba spp. commonly found in human stools
Background: Six species of the genusEntamoeba, i.e.,E. histolytica, E. dispar, E. moshkovskii, E. polecki, E. coli, and E. hartmaniican be found in human stools. Among these, onlyE. histolyticais considered to be pathogenic, causing intestinal and extra-intestinal disease, but it is morphologically identical toE. disparandE. moshkovskii. In general,E. polecki,E. coli, andE. hartmaniican be differentiated morphologically fromE. histolytica, but some of their diagnostic morphologic features may overlap creating issues for the differential diagnosis. Moreover, the previous inability to differentiate amongEntamoebaspecies has limited epidemiologic information onE histolytica. The objective of this study was to develop a rapid, high-throughput screening method using Luminex technique for the simultaneous detection and differentiation ofEntamoebaspecies.Methods: PCR amplification was performed with biotinylatedEntamoebasp 18S rRNA gene primers, designed to amplify a fragment ranging from 382 to 429 bp of theEntamoebaspp studied. Regions of this fragment that could differentiate amongE. histolytica,E. moshkovskii, E. dispar, E. hartmaniiandE. coliwere selected to design hybridization probes to link to Luminex beads. The assay was standardized with cloned DNA samples of each species and evaluated with 24 DNA extracts from samples obtained from individuals diagnosed with these amebas in their stools.Results: Using this approach we were able to correctly identifyE. histoltyica,E. dispar,E hartmanni,E. coliandE. moshkovskiiin all specimens studied. From twenty four samples tested by microscopy, PCR/DNA Sequencing and real-time PCR, 100% agreed with PCR-Luminex assay for identification ofE. dispar, E. moshkovskii, E. hartmanni, E. histolytica,andE. coli.Conclusion: These results show that this method could be used in the diagnostic detection ofEntamoebaspp in fecal samples. This diagnostic test was useful to clearly distinguish E histolytica from other species and also to strengthen epidemiologic data onEntamoebaspp.
- 15 March 2013
- Published by Springer Nature in Parasites & Vectors
- Vol. 6 (1) , 69
Open AccessLUMINEX®: a new technology for the simultaneous identification of five Entamoeba spp. commonly found in human stools
Background: Six species of the genusEntamoeba, i.e.,E. histolytica, E. dispar, E. moshkovskii, E. polecki, E. coli, and E. hartmaniican be found in human stools. Among these, onlyE. histolyticais considered to be pathogenic, causing intestinal and extra-intestinal disease, but it is morphologically identical toE. disparandE. moshkovskii. In general,E. polecki,E. coli, andE. hartmaniican be differentiated morphologically fromE. histolytica, but some of their diagnostic morphologic features may overlap creating issues for the differential diagnosis. Moreover, the previous inability to differentiate amongEntamoebaspecies has limited epidemiologic information onE histolytica. The objective of this study was to develop a rapid, high-throughput screening method using Luminex technique for the simultaneous detection and differentiation ofEntamoebaspecies.Methods: PCR amplification was performed with biotinylatedEntamoebasp 18S rRNA gene primers, designed to amplify a fragment ranging from 382 to 429 bp of theEntamoebaspp studied. Regions of this fragment that could differentiate amongE. histolytica,E. moshkovskii, E. dispar, E. hartmaniiandE. coliwere selected to design hybridization probes to link to Luminex beads. The assay was standardized with cloned DNA samples of each species and evaluated with 24 DNA extracts from samples obtained from individuals diagnosed with these amebas in their stools.Results: Using this approach we were able to correctly identifyE. histoltyica,E. dispar,E hartmanni,E. coliandE. moshkovskiiin all specimens studied. From twenty four samples tested by microscopy, PCR/DNA Sequencing and real-time PCR, 100% agreed with PCR-Luminex assay for identification ofE. dispar, E. moshkovskii, E. hartmanni, E. histolytica,andE. coli.Conclusion: These results show that this method could be used in the diagnostic detection ofEntamoebaspp in fecal samples. This diagnostic test was useful to clearly distinguish E histolytica from other species and also to strengthen epidemiologic data onEntamoebaspp.